Genflow Biosciences (LON:GENF) Releases Earnings Results

Genflow Biosciences (LON:GENF) posted its quarterly earnings results on Tuesday. The company reported GBX (0.08) EPS for the quarter, Digital Look Earnings reports. Genflow Biosciences had a negative net margin of 170.64% and a positive return on equity of 332.06%.

Genflow Biosciences Trading Up 0.2%

Shares of Genflow Biosciences stock opened at GBX 1.98 on Tuesday. The company has a 50 day moving average of GBX 2.01 and a 200-day moving average of GBX 2.08. Genflow Biosciences has a 1-year low of GBX 0.90 and a 1-year high of GBX 3.12. The company has a market cap of £11.21 million, a PE ratio of -5.96 and a beta of 2.29.

Genflow Biosciences Company Profile

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.